Search

STAAR Surgical Co

Lezárt

SzektorEgészségügy

26.14 3.36

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

24.7

Maximum

26.2

Fő mutatók

By Trading Economics

Bevétel

5.2M

5.2M

Értékesítés

36M

94M

Egy részvényre jutó nyereség

-0.23

Profit margin

5.567

Munkavállalók

921

EBITDA

19M

10M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+18.44% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-135M

1.3B

Előző nyitás

22.78

Előző zárás

26.14

Hangulat hírek alapján

By Acuity

23%

77%

79 / 340 Rangsor szerint Healthcare

STAAR Surgical Co Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 14. 23:46 UTC

STAAR Surgical Co. shares declined after-market, reflecting broader market sentiment amid an unexpected drop in U.S. retail sales for July.

2026. aug. 13. 20:02 UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

2026. aug. 12. 23:56 UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

2026. aug. 11. 20:01 UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

2026. aug. 10. 20:02 UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

2026. aug. 7. 22:56 UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

2026. aug. 6. 20:03 UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

2026. aug. 5. 20:02 UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

2026. aug. 4. 19:51 UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

2026. aug. 3. 20:03 UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

2026. júl. 31. 19:52 UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

2026. júl. 30. 19:29 UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

2026. júl. 29. 22:11 UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

2026. júl. 28. 18:56 UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

2026. júl. 27. 19:07 UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

2026. júl. 22. 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

2026. júl. 21. 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

2026. júl. 20. 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Társak összehasonlítása

Árváltozás

STAAR Surgical Co Előrejelzés

Célár

By TipRanks

18.44% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 30 USD  18.44%

Magas 40 USD

Alacsony 20 USD

7 Wall Street elemző 12 hónapos célárain alapulva a(z)STAAR Surgical Co termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

7 ratings

2

Vétel

4

Tartás

1

Eladás

Hangulat

By Acuity

79 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat